SS
BBIO icon

SBI Securities’s BridgeBio Pharma BBIO Stock Holding History

SBI Securities’s Portfolio BBIO Stock Details BBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$21.2K Buy
284
+120
+73% +$8.4K ﹤0.01% 1525
2026
Q1 		$12.2K Sell
164
-101
-38% -$7.32K ﹤0.01% 1642
2025
Q4 		$20.3K Buy
265
+239
+919% +$15.7K ﹤0.01% 1438
2025
Q3 		$1.35K Sell
26
-1
-4% -$49 ﹤0.01% 2573
2025
Q2 		$1.17K Buy
27
+15
+125% +$546 ﹤0.01% 2617
2025
Q1 		$415 Hold
12
– – ﹤0.01% 2935
2024
Q4 		$329 Buy
+12
New +$310 ﹤0.01% 3049

Other funds holding BBIO

JT
Jupiter Topco New York $245B AUM
KKRC
Kohlberg Kravis Roberts & Co New York $5.71B AUM 72.37% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
ACM
Aisling Capital Management New York $472M AUM 106.83% 1-Year Est. Return

SBI Securities's BBIO Position: Q2 2026 in Review

SBI Securities increased its BridgeBio Pharma (BBIO) stake by 73% in Q2 2026, buying an estimated $8.4K and bringing the position to 284 shares worth $21.2K. The position accounts for ﹤0.01% of the portfolio, ranked #1525.

SBI Securities first reported a position in BBIO in Q4 2024 and has held it in 7 quarters since. 474 funds tracked by Wall St. Rank hold BBIO as of Q2 2026.

  • SBI Securities held 284 shares of BridgeBio Pharma worth $21.2K as of Q2 2026.
  • SBI Securities bought 120 BridgeBio Pharma shares in Q2 2026, an estimated $8.4K.
  • BridgeBio Pharma made up ﹤0.01% of SBI Securities's portfolio in Q2 2026, its #1525 holding.
  • SBI Securities first reported a position in BridgeBio Pharma in Q4 2024 and has held it in 7 quarters since.
  • 474 funds tracked by Wall St. Rank held BridgeBio Pharma as of Q2 2026.

Based on SBI Securities's 13F filing for Q2 2026, filed 23 Jul 2026.